AdvanSix (ASIX) Competitors $29.34 -0.45 (-1.51%) (As of 02:24 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ASIX vs. CC, MEOH, PCT, PRM, TROX, NGVT, UAN, VHI, ECVT, and WLKPShould you be buying AdvanSix stock or one of its competitors? The main competitors of AdvanSix include Chemours (CC), Methanex (MEOH), PureCycle Technologies (PCT), Perimeter Solutions (PRM), Tronox (TROX), Ingevity (NGVT), CVR Partners (UAN), Valhi (VHI), Ecovyst (ECVT), and Westlake Chemical Partners (WLKP). These companies are all part of the "chemicals" industry. AdvanSix vs. Chemours Methanex PureCycle Technologies Perimeter Solutions Tronox Ingevity CVR Partners Valhi Ecovyst Westlake Chemical Partners AdvanSix (NYSE:ASIX) and Chemours (NYSE:CC) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, community ranking, risk, earnings and dividends. Do institutionals and insiders have more ownership in ASIX or CC? 86.4% of AdvanSix shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 5.6% of AdvanSix shares are held by insiders. Comparatively, 0.5% of Chemours shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to ASIX or CC? In the previous week, AdvanSix had 6 more articles in the media than Chemours. MarketBeat recorded 18 mentions for AdvanSix and 12 mentions for Chemours. AdvanSix's average media sentiment score of 0.86 beat Chemours' score of 0.67 indicating that AdvanSix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdvanSix 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 3 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ASIX or CC? Chemours received 381 more outperform votes than AdvanSix when rated by MarketBeat users. However, 65.62% of users gave AdvanSix an outperform vote while only 60.91% of users gave Chemours an outperform vote. CompanyUnderperformOutperformAdvanSixOutperform Votes25065.62% Underperform Votes13134.38% ChemoursOutperform Votes63160.91% Underperform Votes40539.09% Which has more volatility & risk, ASIX or CC? AdvanSix has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Is ASIX or CC a better dividend stock? AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.1%. Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 4.9%. AdvanSix pays out 213.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out 123.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio. Do analysts prefer ASIX or CC? AdvanSix presently has a consensus price target of $38.00, suggesting a potential upside of 27.56%. Chemours has a consensus price target of $25.00, suggesting a potential upside of 21.48%. Given AdvanSix's stronger consensus rating and higher possible upside, research analysts clearly believe AdvanSix is more favorable than Chemours.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdvanSix 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Chemours 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Which has preferable earnings and valuation, ASIX or CC? AdvanSix has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdvanSix$1.53B0.52$54.62M$0.3099.30Chemours$6.03B0.51-$238M$0.8125.41 Is ASIX or CC more profitable? Chemours has a net margin of 2.16% compared to AdvanSix's net margin of 0.57%. Chemours' return on equity of 33.21% beat AdvanSix's return on equity.Company Net Margins Return on Equity Return on Assets AdvanSix0.57% 1.03% 0.51% Chemours 2.16%33.21%3.14% SummaryAdvanSix and Chemours tied by winning 10 of the 20 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get AdvanSix News Delivered to You Automatically Sign up to receive the latest news and ratings for ASIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASIX vs. The Competition Export to ExcelMetricAdvanSixPlastics materials & resins IndustryMaterials SectorNYSE ExchangeMarket Cap$795.69M$8.78B$2.81B$19.28BDividend Yield2.26%2.34%5.23%3.57%P/E Ratio99.3025.86115.6736.88Price / Sales0.521.36564,192.5614.93Price / Cash6.0810.2123.5120.54Price / Book1.091.893.605.42Net Income$54.62M$234.47M$145.88M$987.01M7 Day Performance5.08%-4.30%-1.02%-0.32%1 Month Performance-6.91%-7.71%0.74%-0.67%1 Year Performance15.11%8.63%29.99%23.17% AdvanSix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASIXAdvanSix4.6332 of 5 stars$29.34-1.5%$38.00+29.5%+15.1%$783.67M$1.53B20.811,450Dividend AnnouncementInsider SellingNews CoverageCCChemours4.1401 of 5 stars$17.82-1.9%$25.00+40.3%-19.9%$2.66B$5.74B22.006,200Earnings ReportAnalyst ForecastNews CoverageMEOHMethanex4.661 of 5 stars$39.09-0.2%$55.38+41.7%-9.8%$2.63B$3.72B18.181,451Upcoming EarningsPCTPureCycle Technologies1.2238 of 5 stars$12.87-1.2%$8.20-36.3%+150.7%$2.12BN/A-13.41146Upcoming EarningsPRMPerimeter Solutions0.9991 of 5 stars$13.48+1.5%$14.50+7.6%+328.8%$1.96B$322.11M-33.70240Upcoming EarningsNews CoverageTROXTronox3.6738 of 5 stars$12.00-1.0%$18.00+50.0%+3.3%$1.90B$2.85B-25.006,500Dividend AnnouncementNGVTIngevity2.6327 of 5 stars$42.00+0.5%$52.17+24.2%-2.1%$1.53B$1.48B-2.701,700Earnings ReportUANCVR Partners1.6146 of 5 stars$65.91-0.4%N/A-16.8%$1.13B$681.48M13.26310Gap DownVHIValhi0.7665 of 5 stars$33.20-2.5%$20.00-39.8%+209.9%$963.45M$2.01B36.892,196ECVTEcovyst4.5448 of 5 stars$7.63+14.6%$11.00+44.2%-19.0%$888.67M$691.10M15.90880High Trading VolumeWLKPWestlake Chemical Partners3.6506 of 5 stars$22.32-0.8%N/A+2.1%$786.36M$1.19B13.86150Dividend Cut Related Companies and Tools Related Companies CC Alternatives MEOH Alternatives PCT Alternatives PRM Alternatives TROX Alternatives NGVT Alternatives UAN Alternatives VHI Alternatives ECVT Alternatives WLKP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ASIX) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvanSix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvanSix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
